OTHER GROUP COMPANIES
market

GlaxoSmithKline's PAT for June quarter stands at Rs116 crore

Revenue (from continuing operations) for the quarter came in at Rs729 crore.

July 26, 2022 10:00 IST | India Infoline News Service
GlaxoSmithKline Pharmaceuticals Limited has declared its financial results for the quarter ended June 30, 2022. 
As per the filing, Revenue (from continuing operations) for the quarter came in at Rs729 crore. Profit After Tax (from continuing operations) at Rs116 crore recorded a growth of 8%. EBITDA margins (from continuing operations) improved by 1.5%.
Sridhar Venkatesh, Managing Director, GlaxoSmithKline Pharmaceuticals Limited, said, "Our results reflect high momentum across general medicines and vaccines during this fiscal quarter.
 The Company has delivered strong underlying growth with market share gains across focus brands.

At around 10:03 AM, Glaxosmithkline Pharmaceuticals was trading at Rs1,487.70 per share down by Rs6.15 or 0.41% from its previous closing of Rs1,493.85 per share on the BSE.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity